CancerVAX, Inc. — Form D/A
CancerVAX, Inc. of SANTA BARBARA, CA, a company, filed a Form D amendment with the SEC on 2024-10-18. The offering totals $10.0M, of which $1.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-10-18
- Form: D/A
- Accession: 0001493152-24-041515
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $10.0M
- Amount sold: $1.0M
- Remaining: $9.0M
- Minimum investment: $100K
- Investors: 1
- Date of first sale: 2023-10-13
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-495745
Issuer
- Name: CancerVAX, Inc.
- CIK: 0001905495
- Entity type: Corporation
- Jurisdiction: NEVADA
- Incorporated: 2021
- Address: 351 PASEO NUEVO, SANTA BARBARA, CA, 93101
- Phone: 805-356-1810
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Byron Elton | Director | Los Angeles, CA |
| Carla Miller | Director | SANTA BARBARA, CA |
| Byron Elton | Executive Officer | Los Angeles, CA |
| Ryan Davies | Director | SANTA BARBARA, CA |
| Ryan Davies | Executive Officer | SANTA BARBARA, CA |
Other filings by this issuer (1)
More